 Lieberman has been critical of Bush's Medicare plan, arguing that in its current state, it does not provide sufficiently for our nation's elderly.In 2005, Lieberman introduced S. 975, the Project BioShield II Act of 2005, to provide incentives to increase research by private sector entities to develop medical countermeasures to
counter bioterrorism threats.The bill seeks to grant liability protection for these drugs and an extension of patents to companies producing drugs needed in case of a bioterrorism attack.